As bacteria become increasingly resistant to antibiotics and other antibacterials, there is a growing need for alternatives. In a study published in the open-access journal PLOS Biology, Tobias Warnecke and colleagues from the University of Oxford and the MRC Laboratory of Medical Sciences, United Kingdom, identified untapped antimicrobials produced by archaea, single-celled organisms that make up one of the three domains of life (the other two being bacteria and eukaryotes, the group that includes us).
Antimicrobials produced by archaea can kill bacteria
